Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial.
- Published in:
- Hematological Oncology, 2009, v. 27, n. 3, p. 130, doi. 10.1002/hon.886
- By:
- Publication type:
- Article
Works matching IS 02780232 AND DT 2009 AND VI 27 AND IP 3
Results: 7
1
2
Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in Elderly acute myeloid leukaemia patients.
- Published in:
- Hematological Oncology, 2009, v. 27, n. 3, p. 148, doi. 10.1002/hon.889
- By:
- Publication type:
- Article
3
CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL.
- Published in:
- Hematological Oncology, 2009, v. 27, n. 3, p. 140, doi. 10.1002/hon.888
- By:
- Publication type:
- Article
4
A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03.
- Published in:
- Hematological Oncology, 2009, v. 27, n. 3, p. 154, doi. 10.1002/hon.891
- By:
- Publication type:
- Article
5
Involved field radiotherapy for limited stage Hodgkin lymphoma: balancing treatment efficacy against long-term toxicities.
- Published in:
- Hematological Oncology, 2009, v. 27, n. 3, p. 115, doi. 10.1002/hon.890
- By:
- Publication type:
- Article
6
New antimicrobial agents for the treatment of bacterial infections in cancer patients.
- Published in:
- Hematological Oncology, 2009, v. 27, n. 3, p. 107, doi. 10.1002/hon.898
- By:
- Publication type:
- Article
7
Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy.
- Published in:
- Hematological Oncology, 2009, v. 27, n. 3, p. 123, doi. 10.1002/hon.901
- By:
- Publication type:
- Article